The first sales of CardioCel in the Middle East and North African (MENA) region. The initial sales of CardioCel have come through an early access program in Qatar. Admedus anticipates additional sales in other MENA countries in the near future.
Admedus entered into a partnership in 2015 with Genpharm to be its exclusive partner for CardioCel in the MENA region. Leveraging Admedus’ existing regulatory approvals outside the region, it is expected that the two companies will work together to produce a number of MENA country product marketing approvals in 2016.
To read the full article with statements from Admedus CEO, Mr Lee Rodne, Click Here http://clients2.weblink.com.au/news/pdf_1%5C01708604.pdf